Transcat, Inc. $TRNS Stock Holdings Raised by Intech Investment Management LLC

Intech Investment Management LLC lifted its stake in shares of Transcat, Inc. (NASDAQ:TRNS) by 19.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,347 shares of the scientific and technical instruments company’s stock after purchasing an additional 1,026 shares during the period. Intech Investment Management LLC’s holdings in Transcat were worth $546,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. Quantbot Technologies LP bought a new stake in Transcat in the first quarter valued at about $76,000. Parkside Financial Bank & Trust bought a new position in Transcat during the 2nd quarter worth approximately $79,000. PNC Financial Services Group Inc. grew its position in shares of Transcat by 1,118.2% in the 2nd quarter. PNC Financial Services Group Inc. now owns 1,072 shares of the scientific and technical instruments company’s stock worth $92,000 after acquiring an additional 984 shares in the last quarter. State of Wyoming bought a new stake in shares of Transcat in the 1st quarter valued at approximately $95,000. Finally, Morgan Dempsey Capital Management LLC raised its position in shares of Transcat by 41.7% during the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 1,352 shares of the scientific and technical instruments company’s stock valued at $116,000 after acquiring an additional 398 shares in the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

TRNS has been the subject of a number of research reports. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Transcat in a report on Monday. Northland Securities set a $95.00 price target on shares of Transcat in a research report on Thursday, October 23rd. Zacks Research raised shares of Transcat from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 7th. HC Wainwright reissued a “buy” rating and issued a $116.00 target price on shares of Transcat in a report on Friday, August 22nd. Finally, Northland Capmk upgraded Transcat from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $110.25.

Transcat Stock Performance

Shares of TRNS stock opened at $56.32 on Friday. Transcat, Inc. has a 12-month low of $52.06 and a 12-month high of $111.45. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.92 and a quick ratio of 2.36. The firm has a market capitalization of $525.35 million, a price-to-earnings ratio of 39.38 and a beta of 0.71. The business has a 50 day simple moving average of $66.23 and a 200 day simple moving average of $76.73.

Transcat (NASDAQ:TRNS) last announced its earnings results on Monday, November 3rd. The scientific and technical instruments company reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.02). Transcat had a net margin of 4.64% and a return on equity of 6.66%. The business had revenue of $82.27 million for the quarter, compared to the consensus estimate of $79.51 million. On average, equities research analysts anticipate that Transcat, Inc. will post 2.3 EPS for the current year.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.